Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone-Reference-Cited by-同舟云学术

Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone

Published:2015-08-27 Issue:1 Volume:4 Page:
ISSN:2193-1801
Container-title:SpringerPlus
language:en
Short-container-title:SpringerPlus

Author:

Epperla Narendranath,McKiernan Fergus

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://link.springer.com/content/pdf/10.1186/s40064-015-1218-x.pdf

Reference49 articles.

1. Abbott Laboratories (2006) Norvir (ritonavir) package insert. North Chicago, IL

2. Arrington-Sanders R, Hutton N et al (2006) Ritonavir–fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents. Pediatr Infect Dis J 25:1044–1048

3. Bhumbra NA, Sahloff EG et al (2007) Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir/ritonavir. Ann Pharmacother 41:1306–1309

4. Carr A, Cooper DA (1998) Lipodystrophy associated with an HIV-protease inhibitor. N Engl J Med 339:1296

5. Chen F, Kearney T et al (1999) Cushing’s syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone. Sex Transm Infect 75:274

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Dynamics in HIV: The Influence of Adrenal Function and Nutritional Status;Circulation Research;2024-05-24

2. Anti-Viral Surfaces in the Fight against the Spread of Coronaviruses;Membranes;2023-04-27

3. Unveiling the prevalence and impact of diabetes on COVID-19;Viral, Parasitic, Bacterial, and Fungal Infections;2023

4. Diabetes Mellitus and COVID-19;COVID-19: Effects in Comorbidities and Special Populations;2022-08-30

5. The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It;Saudi Journal of Biological Sciences;2022-05